OpACIN-neo: A multicenter phase II study to identify the optimal neo-adjuvant combination scheme of ipilimumab (IPI) and nivolumab (NIVO)

Authors :: Christian U. Blank
Willem M.C. Klop
Alexander Guminski
María Jesús González González
A.C.J. van Akkooi
Richard A. Scolyer
B.A. van de Wiel
Karolina Sikorska
Johan Hansson
Robyn P. M. Saw
Georgina V. Long
A.M. Menzies
Hanna Eriksson
Carolien Bierman
Annegien Broeks
C. Adhikari
Andrew J. Spillane
Oscar Krijgsman
Lindsay G Grijpink-Ongering
Elisa A. Rozeman
Source :: Annals of Oncology. 29:viii734
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: 0301 basic medicine
Oncology
medicine.medical_specialty
business.industry
Phases of clinical research
Ipilimumab
Hematology
Neo adjuvant
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Pharmaceutical Adjuvants
030220 oncology & carcinogenesis
Internal medicine
medicine
Nivolumab
business
medicine.drug

Full Text Access

Tools